The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

No abstract available.

Information

Citation

Rzepka AM, Wong L, Chaudhry M, Sproule BA, He N, Cadarette SM. Can Pharm J (Ott). 2022; 155(4):194-9. Epub 2022 Jun 20.

View Source

Discover More

Journal Article

01/05/2025

Evaluating the median p-value method for assessing the statistical significance of tests when using multiple imputation

Austin PC, Eekhout I, van Buuren S. J Appl Stat. 2025; 52(6):1161-1176. Epub 2024; Oct 25.

Journal Article

28/04/2025

Association between primary care physicians’ practice models and referral rates to specialists: a sex-based cross-sectional study

Rahman B, Kirkwood D, Babe G, Griffith LE, Price D, Correia RH, Dash D, Lapointe-Shaw L, Costa AP. PLoS One. 2025; 20(4):e0322175.

Journal Article

28/04/2025

SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors

Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. JAMA Intern Med. 2025; Apr 28 [Epub ahead of print].

See All

The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Sites

Discover More

Evaluating the median p-value method for assessing the statistical significance of tests when using multiple imputation

Association between primary care physicians’ practice models and referral rates to specialists: a sex-based cross-sectional study

SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors